South Korea Blood Glucose Monitoring Devices Market Size, Share, and COVID-19 Impact Analysis, By Type (Self-Monitoring Blood Glucose Devices (Glucometer Devices, Test Strips, Lancets) Continuous Blood Glucose Monitoring Devices (Sensors, Durables (Receivers and Transmitters))), and South Korea Blood Glucose Monitoring Devices Market Insights, Industry Trend, Forecasts to 2035

South Korea Blood Glucose Monitoring Devices Market Insights Forecasts to 2035

• The South Korea Blood Glucose Monitoring Devices Market Size was estimated at USD 221.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.72% from 2025 to 2035
• The South Korea Blood Glucose Monitoring Devices Market Size is Expected to Reach USD 554.9 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Blood Glucose Monitoring Devices Market is anticipated to reach USD 554.9 million by 2035, growing at a CAGR of 8.72% from 2025 to 2035. Increasing awareness of the significance of diabetes management and early disease detection, the growing emphasis on health and wellness, and the accessibility of health insurance policies are some of the major factors propelling the market.

Market Overview

The South Korea blood glucose monitoring devices market encompasses the development, manufacturing, and use of medical devices intended to measure and track blood glucose levels are all included in the South Korean market for blood glucose monitoring devices. These tools are essential for people with diabetes because they allow them to monitor their blood sugar levels and make well-informed choices about their medication, diet, and exercise. Additionally, growing public awareness of the significance of diabetes care is providing South Korean industry investors with profitable growth prospects. Additionally, there is a growing need for affordable, user-friendly blood glucose monitoring devices. This is helping the business expand in the nation, as is the growing emphasis on general health and wellness. In addition, the growing advancement of continuous glucose monitoring (CGM) systems and smart glucose meters for better patient outcomes and satisfaction is supporting market expansion. Furthermore, the industry is expanding due to the abundance of health insurance plans available in the nation.

Report Coverage

This research report categorizes the market for the South Korea blood glucose monitoring devices market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea blood glucose monitoring devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea blood glucose monitoring devices market.

Driving Factors

the one of the main factors favorably impacting the South Korean market is the growing demand for contemporary blood glucose monitoring devices that enable data sharing with family members and healthcare providers. Additionally, the country's market is expanding due to the growing use of blood glucose monitoring devices among the elderly population, who are more likely to develop diabetes. In addition, a favorable market outlook is being provided by the rising demand for blood glucose monitoring devices due to the rising incidence of diabetes in the general population. Additionally, the market is expanding due to the growing use of blood glucose monitoring devices with remote monitoring features, which enable prompt interventions.

Restraining Factors

Test strips are only allowed to be sold to pharmacies in South Korea due to the Pharmaceutical Affairs Law, which classifies them as pharmacologic supplies. Because pharmacies might not carry all necessary brands, this rule has made it harder for patients to get test strips that work with their glucose meters.

Market Segmentation

The South Korea blood glucose monitoring devices market share is classified into type.

• The self-monitoring blood glucose devices segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea blood glucose monitoring devices market is segmented by type into self-monitoring blood glucose devices and continuous blood glucose monitoring devices. Among these, the self-monitoring blood glucose devices segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Regular blood glucose monitoring is now crucial for efficient disease management as the number of people with diabetes diagnoses rises. Additionally, more consumers are adopting SMBG devices as a result of government healthcare initiatives and increased awareness of early detection. Monitoring is also becoming more convenient thanks to technological developments like smartphone-connected smart glucometers.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea blood glucose monitoring devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Korea Co. Ltd.
• Arkray Inc.
• Ascensia Diabetes Care Korea Ltd.
• Dexcom Inc.
• Roche Holding AG
• Others

Recent Developments:

• In June 2023, i-SENS, a CGM manufacturer based in South Korea, obtained regulatory clearance for CareSens Air, the first domestically developed CGM device. In March, i-SENS submitted the required documentation to the government for approval. The Ministry of Food and Drug Safety did not request additional supporting paperwork, allowing for earlier-than-expected approval.

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Blood Glucose Monitoring Devices Market based on the below-mentioned segments:

South Korea Blood Glucose Monitoring Devices Market, By Type

• Self-Monitoring Blood Glucose Devices
  • Glucometer Devices
  • Test Strips
  • Lancets

• Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Durables (Receivers and Transmitters)